Analystreport

Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its price target raised by analysts at Wells Fargo & Company from $6.00 to $7.00. They now have an "equal weight" ra

Adaptimmune Therapeutics plc - American Depositary Shares  (ADAP) 
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am Check Earnings Report